# Inovio Pharmaceuticals, Inc.: Form 8-K, filed Oct 10, 2023

- Company: [Inovio Pharmaceuticals, Inc.](/companies/ino.md) (CIK 1055726)
- Form: 8-K
- Filed: 2023-10-10
- Accepted by EDGAR: Oct 10, 2023, 16:00 ET
- Period: 2023-10-10
- Accession: 0001193125-23-253450
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1055726/000119312523253450/d567242d8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1055726/000119312523253450/

## Items reported

- Item 7.01: Regulation FD disclosure
- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1055726/000119312523253450/d567242d8k.htm

Filed Oct 10, 2023.
Source: SEC EDGAR, the filing index for accession 0001193125-23-253450. Last ingested by Listed: Nov 11, 2026, 00:27 ET. No prices; not investment advice.
